• Mashup Score: 0

    Objective The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) system is a novel and simple SLE disease activity instrument, consisting of a tandem clinician-reported (ClinRO) and patient-reported (PRO) outcome measure. The aim of this study was to compare the LFA-REAL system with other SLE activity measures in the phase III trial of ustekinumab in patients with active SLE. Methods This was a prespecified analysis of data from a randomised, double-blind, placebo-controlled, parallel-group trial conducted at 140 sites in 20 countries. Correlations were evaluated between the LFA-REAL ClinRO and PRO with a panel of clinician-reported and patient-reported disease activity measures commonly used in SLE clinical trials at baseline, week 24 and week 52. All p values are reported as nominal. Results Trial participants included 516 patients with SLE with a mean (SD) age of 43.5 (8.9), of whom 482 (93.4%) were female. The LFA-REAL ClinRO correlated with Physician Glob

    Tweet Tweets with this article
    • Interested to #learn more from the new #podcast ? The following article provides #data from this #study support further #development of the #LFA-REAL #SLE #lupus #autoimmunity #rheumatology https://t.co/LQDl3Dhegy

  • Mashup Score: 1

    SKILL is written for those who want to become the best – no matter what they’re trying to achieve. This book provides guidelines – via 40 practical tips and processes – to fulfill anyone’s natural ability. It’s about becoming the master of your own fate, your own skills and your own success. Grea…

    Tweet Tweets with this article
    • Grade your #performance. Be harsh. Foster self-critique & #analysis... Take notes on areas that need #improvement, and #study them as you make a forceful #plan to not repeat the same #mistakes.. SKILL: The Book https://t.co/VXcMLEBdsA📕 #skill #practice #mastery #grit 🥇 https://t.co/jgixvJiH1x

  • Mashup Score: 0

    July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, has announced the commencement of an international, multi-site observational study, ACTION PMR (ACuTe Ischemic strOke detectioN with Portable MR). To support its acute stroke care initiatives, Hyperfine Inc. has…

    Tweet Tweets with this article
    • @DAICeditor @Hyperfine Hyperfine announced the commencement of an international, multi-site observational #study, #ACTION_PMR (ACuTe Ischemic strOke detectioN with Portable #MR): https://t.co/Vg0qp3Pj8k

  • Mashup Score: 0

    Explanatory studies, conducted under tightly controlled circumstances, could hinder the integration of technology in clinical settings by underreporting key study characteristics.

    Tweet Tweets with this article
    • Explanatory studies, conducted under tightly controlled conditions, could hinder the merging of technology in clinical settings by underreporting key #study characteristics. https://t.co/YFS4qAaE0n https://t.co/Hly3SEqxsd